
Current Price | $2.07 | Mkt Cap | $5.1M |
---|---|---|---|
Open | $2.60 | P/E Ratio | -0.18 |
Prev. Close | $2.07 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $1.91 - $2.60 | Volume | 932,067 |
52-Wk Range | $1.91 - $38.18 | Avg. Daily Vol. | 54,021 |
Current Price | $2.07 | Mkt Cap | $5.1M |
---|---|---|---|
Open | $2.60 | P/E Ratio | -0.18 |
Prev. Close | $2.07 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $1.91 - $2.60 | Volume | 932,067 |
52-Wk Range | $1.91 - $38.18 | Avg. Daily Vol. | 54,021 |
The best Bull and Bear pitches based on recency and number of recommendations.
I got tuned into Adamis by Jake King, who runs the PropThink analytic service at propthink.com and can be found on Twitter at @FajaJake. If you're serious about biotech trading, he's a must-follow and you should consider investing in his service if… More
Read the most recent pitches from players about ADMP.
Recs
more room to climb on approval
Recs
These guys are repackaging a proven drug in a cheaper delivery system. Never mind if the FDA picks on them, eventually they will prevail.
Recs
ADMP is a specialty pharma focusing on low risk "quasi-generic" drugs in large target markets. They need to take very little market share to reap huge rewards to shareholders. ADMP has 4 inhaler Ph3 ready candidates and one allergy product already submitted to the FDA. Their largest potantial product is teh APC-5000 inhlaer they obtained from 3M and has been shown to be more effective than Advair in a recent PK study. They have backing by healthcare hedge fund Sio Capital and their very successful manager, Dr. Micahel Castor.
Find the members with the highest scoring picks in ADMP.
shake656 (74.16) Score: +171.89
The Score Leader is the player with the highest score across all their picks in ADMP.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
vinvestor777 | < 20 | 1/22/2021 |
![]() |
5Y | $2.33 | -13.73% | +9.93% | -23.67 | 0 Comment | |
TheIzzishWizzy | 86.72 | 6/17/2016 |
![]() |
5Y | $3.10 | -35.16% | +103.08% | -138.24 | 1 Comment | |
danielim | < 20 | 8/7/2015 |
![]() |
5Y | $3.76 | -46.54% | +102.10% | -148.65 | 0 Comment | |
tytwins13 | 21.05 | 5/18/2015 |
![]() |
5Y | $4.21 | -52.26% | +97.99% | -150.25 | 0 Comment | |
2008Rehab | < 20 | 5/4/2015 |
![]() |
5Y | $4.55 | -55.82% | +98.94% | -154.76 | 1 Comment | |
![]() |
jwburke | < 20 | 4/14/2015 |
![]() |
3Y | $4.49 | -55.23% | +101.39% | -156.62 | 2 Comments |
brooklyn053 | 20.64 | 8/24/2015 |
![]() |
5Y | $3.50 | -42.57% | +121.73% | -164.30 | 0 Comment | |
djs344 | < 20 | 2/13/2015 |
![]() |
5Y | $6.55 | -69.31% | +100.99% | -170.31 | 2 Comments | |
no1dreamer | < 20 | 10/14/2014 |
![]() |
5Y | $3.88 | -48.20% | +123.17% | -171.37 | 0 Comment | |
bwalk037 | 28.08 | 4/1/2016 |
![]() |
3Y | $6.17 | -67.43% | +104.22% | -171.65 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.